Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Jul 24;285(6337):253–255. doi: 10.1136/bmj.285.6337.253

Rubella vaccination: persistence of antibodies for up to 16 years.

S O'Shea, J M Best, J E Banatvala, W C Marshall, J A Dudgeon
PMCID: PMC1499591  PMID: 6807437

Abstract

Sera from 123 volunteers vaccinated six to 16 years previously with one of four rubella vaccines (Cendehill, RA27/3, HPV77-DE5, and To-336) were tested for rubella antibodies by single radial haemolysis and radioimmunoassay. By radioimmunoassay 110 (89.4%) of the vaccinees had antibody concentrations greater than the minimum immune titre (that is, greater than 15,000 IU/1), 11 (8.9%) were seropositive but had concentrations less than or equal to 15,000 IU/1, and two (1.6%) were seronegative. Eight (6.5%) were seronegative by single radial haemolysis, of whom five had received Cendehill vaccine. Six to eight years after vaccination subjects who had received Cendehill vaccine had the lowest geometric mean titre of antibody by radioimmunoassay while the subjects who had received HPV77-DE5 vaccine had the highest. Although antibody concentrations less than or equal to 15,000 IU/1 were not detected among subjects given RA27/3 vaccine six to eight years previously, such low levels were detected in two (15.4%) vaccinated 11-16 years previously. These results emphasise the importance of long-term surveillance programmes so that vaccination policies may be reviewed.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour H. H., Jr, Amren D. P. Rubella, measles and mumps antibodies following vaccination of children. A potential rubella problem. Am J Dis Child. 1978 Jun;132(6):573–577. doi: 10.1001/archpedi.1978.02120310037006. [DOI] [PubMed] [Google Scholar]
  2. Balfour H. H., Jr, Groth K. E., Edelman C. K., Amren D. P., Best J. M., Banatvala J. E. Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet. 1981 May 16;1(8229):1078–1080. doi: 10.1016/s0140-6736(81)92243-1. [DOI] [PubMed] [Google Scholar]
  3. Balfour H. H., Jr Rubella reimmunization now. Am J Dis Child. 1979 Dec;133(12):1231–1233. doi: 10.1001/archpedi.1979.02130120023001. [DOI] [PubMed] [Google Scholar]
  4. Best J. M., Banatvala J. E., Bowen J. M. New Japanese rubella vaccine: comparative trials. Br Med J. 1974 Jul 27;3(5925):221–224. doi: 10.1136/bmj.3.5925.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Best J. M., Harcourt G. C., Druce A., Palmer S. J., O'Shea S., Banatvala J. E. Rubella immunity by four different techniques: results of challenge studies. J Med Virol. 1980;5(3):239–247. doi: 10.1002/jmv.1890050308. [DOI] [PubMed] [Google Scholar]
  6. Best J. M., Harcourt G. C., O'Shea S., Banatvala J. E. Rubella vaccines. Lancet. 1979 Sep 29;2(8144):690–691. doi: 10.1016/s0140-6736(79)92084-1. [DOI] [PubMed] [Google Scholar]
  7. Dudgeon J. A., Marshall W. C., Peckham C. S., Hawkins G. T. Clinical and laboratory studies with rubella vaccines in adults. Br Med J. 1969 Feb 1;1(5639):271–276. doi: 10.1136/bmj.1.5639.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harcourt G. C., Best J. M., Banatvala J. E. Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis. 1980 Aug;142(2):145–155. doi: 10.1093/infdis/142.2.145. [DOI] [PubMed] [Google Scholar]
  9. Herrmann K. L., Halstead S. B., Wiebenga N. H. Rubella antibody persistence after immunization. JAMA. 1982 Jan 8;247(2):193–196. [PubMed] [Google Scholar]
  10. Hillary I. B., Griffith A. H. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine. Br Med J. 1980 Jun 28;280(6231):1580–1581. doi: 10.1136/bmj.280.6231.1580-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Horstmann D. M. Controlling rubella: problems and perspectives. Ann Intern Med. 1975 Sep;83(3):412–417. doi: 10.7326/0003-4819-83-3-412. [DOI] [PubMed] [Google Scholar]
  12. Kurtz J. B., Mortimer P. P., Mortimer P. R., Morgan-Capner P., Shafi M. S., White G. B. Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) 1980 Apr;84(2):213–222. doi: 10.1017/s0022172400026711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Macdonald H., Tobin J. O., Cradock-Watson J. E., Lomax J. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines. J Hyg (Lond) 1978 Jun;80(3):337–347. doi: 10.1017/s0022172400024785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marshall W. C., Peckham C. S., Darby C. P., Dudgeon J. A., Hawkins G. T. Further studies with rubella vaccines in adults and children. Practitioner. 1971 Nov;207(241):632–638. [PubMed] [Google Scholar]
  15. O'Shea S., Parsons G., Best J. M., Banatvala J. E., Balfour H. H., Jr How well do low levels of rubella antibody protect? Lancet. 1981 Dec 5;2(8258):1284–1284. doi: 10.1016/s0140-6736(81)91517-8. [DOI] [PubMed] [Google Scholar]
  16. Zealley H., Edmond E. Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination. Br Med J (Clin Res Ed) 1982 Feb 6;284(6313):382–384. doi: 10.1136/bmj.284.6313.382. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES